FASEB SRC on Matricellular Proteins in Development, Health, and Disease

FASEB SRC 关于基质细胞蛋白在发育、健康和疾病中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Interactions between cells and their surrounding extracellular matrix (ECM) are the basis for multi-cellular life and essential for cell and tissue organization in all metazoan organisms. Structural ECM components such as collagens, fibronectin, and laminins, are secreted by cells and assembled extracellularly into organized sheets (basement membranes) or three-dimensional fibrils and networks (connective tissue matrix). ECM also contains less abundant, but highly regulated, components that play important roles in controlling cell behavior and matrix remodeling. Because of their distinctive localization and functional attributes in the ECM, these proteins have been termed matricellular proteins and include members of the thrombospondin, CCN, tenascin, osteopontin, periostin, fibulin, and SPARC families. The purpose of this conference is to focus on these matriceullular proteins and to examine their structure-function relationships and their impact on signaling networks that play key roles in disease, homeostasis, repair, and development. Through lectures and poster sessions, established scientists and young investigators will address current topics in matricellular protein structure, gene regulation, roles in development in mammalian and non-mammalian model systems, and impact on growth factors. These functions will be examined in the context of their roles in tissue remodeling, inflammation, fibrosis, injury/stress responses, development, neurobiology, metabolic regulation, angiogenesis, and immunity. The program will emphasize basic and translational applications to inflammation and immunity, fibrosis, diabetes and obesity, cardiovascular disease, cancer, neurologic, and musculoskeletal diseases. The program will feature full length talks from invited speakers, short talks selected from abstract submissions which will feature young scientists, and robust poster sessions. Inclusion of women, minorities, and young scientists has been emphasized in developing the program. Invited speakers represent leaders in the basic sciences, clinical investigators who are defining the roles of matricellular proteins in inherited disorders and acquired diseases, and investigators developing novel therapeutics to treat these diseases. The overall objectives of this meeting are to foster new knowledge in the field of matricellular proteins that will lead to development of therapeutics for the treatment of human diseases, facilitate the development of new multidisciplinary collaborations and research directions, and encourage the development of young scientists in this field.
描述(由申请人提供):细胞与其周围细胞外基质(ECM)之间的相互作用是多细胞生命的基础,对所有后生动物生物体中的细胞和组织组织至关重要。结构ECM组分如胶原蛋白、纤连蛋白和层粘连蛋白由细胞分泌并在细胞外组装成有组织的片(基底膜)或三维原纤维和网络(结缔组织基质)。ECM还含有不太丰富但高度调节的组分,其在控制细胞行为和基质重塑中起重要作用。由于它们在ECM中的独特定位和功能属性,这些蛋白质被称为基质细胞蛋白,并且包括血小板反应蛋白、CCN、腱生蛋白、骨桥蛋白、骨膜蛋白、纤蛋白和骨桥蛋白家族的成员。本次会议的目的是集中在这些matriceullular蛋白,并检查它们的结构-功能关系及其对信号网络的影响,在疾病,稳态,修复和发展中发挥关键作用。通过讲座和海报会议,建立科学家和年轻的研究人员将解决当前的主题在matricellular蛋白质结构,基因调控,在哺乳动物和非哺乳动物模型系统的发展中的作用,以及对生长因子的影响。这些功能将在其在组织重塑,炎症,纤维化,损伤/应激反应,发育,神经生物学,代谢调节,血管生成和免疫中的作用的背景下进行检查。该计划将强调炎症和免疫,纤维化,糖尿病和肥胖,心血管疾病,癌症,神经系统和肌肉骨骼疾病的基本和翻译应用。该计划将包括来自受邀演讲者的完整演讲,从年轻科学家的摘要提交中选择的简短演讲,以及强大的海报会议。在制定该计划时强调了妇女、少数民族和青年科学家的参与。受邀演讲者代表了基础科学的领导者,临床研究人员,他们正在定义基质细胞蛋白在遗传性疾病和获得性疾病中的作用, 开发新的疗法来治疗这些疾病。本次会议的总体目标是促进在matricellular蛋白领域的新知识,这将导致治疗人类疾病的治疗方法的发展,促进新的多学科合作和研究方向的发展,并鼓励年轻科学家在这一领域的发展。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Revisiting the matricellular concept.
  • DOI:
    10.1016/j.matbio.2014.07.005
  • 发表时间:
    2014-07
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Murphy-Ullrich, Joanne E.;Sage, E. Helene
  • 通讯作者:
    Sage, E. Helene
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOANNE E MURPHY-ULLRICH其他文献

JOANNE E MURPHY-ULLRICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOANNE E MURPHY-ULLRICH', 18)}}的其他基金

The thrombospondin1-TGF-beta axis in multiple myeloma
多发性骨髓瘤中的血小板反应蛋白 1-TGF-β 轴
  • 批准号:
    8893914
  • 财政年份:
    2014
  • 资助金额:
    $ 0.4万
  • 项目类别:
The thrombospondin1-TGF-beta axis in multiple myeloma
多发性骨髓瘤中的血小板反应蛋白 1-TGF-β 轴
  • 批准号:
    9324935
  • 财政年份:
    2014
  • 资助金额:
    $ 0.4万
  • 项目类别:
The thrombospondin1-TGF-beta axis in multiple myeloma
多发性骨髓瘤中的血小板反应蛋白 1-TGF-β 轴
  • 批准号:
    8761464
  • 财政年份:
    2014
  • 资助金额:
    $ 0.4万
  • 项目类别:
The thrombospondin1-TGF-beta axis in multiple myeloma
多发性骨髓瘤中的血小板反应蛋白 1-TGF-β 轴
  • 批准号:
    9111835
  • 财政年份:
    2014
  • 资助金额:
    $ 0.4万
  • 项目类别:
Thrombospondins and other matricellular proteins in tissue organization and homeo
组织组织和同源性中的血小板反应蛋白和其他基质细胞蛋白
  • 批准号:
    8004379
  • 财政年份:
    2010
  • 资助金额:
    $ 0.4万
  • 项目类别:
Fibroblast control of TGF-beta activation by Thy-1 and lung fibrosis
Thy-1 成纤维细胞对 TGF-β 激活的控制和肺纤维化
  • 批准号:
    7176258
  • 财政年份:
    2007
  • 资助金额:
    $ 0.4万
  • 项目类别:
Fibroblast control of TGF-beta activation by Thy-1 and lung fibrosis
Thy-1 成纤维细胞对 TGF-β 激活的控制和肺纤维化
  • 批准号:
    7341144
  • 财政年份:
    2007
  • 资助金额:
    $ 0.4万
  • 项目类别:
Thrombospondin1 antagonists and diabetic nephropathy
血小板反应蛋白1拮抗剂与糖尿病肾病
  • 批准号:
    7590423
  • 财政年份:
    2007
  • 资助金额:
    $ 0.4万
  • 项目类别:
Thrombospondin1 antagonists and diabetic nephropathy
血小板反应蛋白1拮抗剂与糖尿病肾病
  • 批准号:
    8055561
  • 财政年份:
    2007
  • 资助金额:
    $ 0.4万
  • 项目类别:
Thrombospondin1 antagonists and diabetic nephropathy
血小板反应蛋白1拮抗剂与糖尿病肾病
  • 批准号:
    7244734
  • 财政年份:
    2007
  • 资助金额:
    $ 0.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了